Market Research Logo

OTC Pharmaceuticals: Global Group of Eight (G8) Industry Guide

INTRODUCTION
What is this report about?
Who is the target reader?
How to use this report
Definitions
GROUP OF EIGHT (G8) OTC PHARMACEUTICALS
Industry Outlook
OTC PHARMACEUTICALS IN CANADA
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC PHARMACEUTICALS IN FRANCE
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC PHARMACEUTICALS IN GERMANY
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC PHARMACEUTICALS IN ITALY
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC PHARMACEUTICALS IN JAPAN
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC PHARMACEUTICALS IN RUSSIA
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC PHARMACEUTICALS IN THE UNITED KINGDOM
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC PHARMACEUTICALS IN THE UNITED STATES
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
COMPANY PROFILES
Leading companies
APPENDIX
Methodology
About MarketLine

OTC Pharmaceuticals: Global Group of Eight (G8) Industry Guide

Introduction

The G8 OTC pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market share, market size (value , and forecast to 2019). The guide also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Features and benefits

  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the G8 OTC pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 OTC pharmaceuticals market
  • Leading company profiles reveal details of key OTC pharmaceuticals market players’ G8 operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the G8 OTC pharmaceuticals market with five year forecasts
  • Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country
Highlights

The G8 countries contributed $71,297.9 million in 2014 to the global otc pharmaceuticals industry, with a compound annual growth rate (CAGR) of 2.4% between 2010 and 2014. The G8 countries are expected to reach a value of $76,902.9 million in 2019, with a CAGR of 1.5% over the 2014-19 period.
Among the G8 nations, the US is the leading country in the otc pharmaceuticals industry, with market revenues of $30,646.1 million in 2014. This was followed by Japan and Germany, with a value of $11,445.9 and $7,521.9 million, respectively.
The US is expected to lead the otc pharmaceuticals industry in the G8 nations with a value of $32,806.2 million in 2016, followed by Japan and Germany with expected values of $11,954.0 and $7,370.2 million, respectively.

Your key questions answered
  • What was the size of the G8 OTC pharmaceuticals market by value in 2014?
  • What will be the size of the G8 OTC pharmaceuticals market in 2019?
  • What factors are affecting the strength of competition in the G8 OTC pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the G8 OTC pharmaceuticals market?


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;